Drugs / I-131 Tositumomab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00484874 | Jun 2007 → Jan 2014 | Hodgkins lymphoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | I-131 Tositumomab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00484874 ↗ |
| Route | Intravenous | “Tositumomab and I-131 tositumomab are given intravenously.” NCT00484874 ↗ |